Here’s how a near-term revival can play out for Avalanche investors

After observing an unrestrained up-channel (yellow) rally for over three months, Avalanche (AVAX) poked its ATH on 21 November. Since then, it has been on a decline while losing the vital $79-mark.  While the 20 EMA (red) refused to show improvement signs and endeavored to jump below the 200 EMA (yellow), AVAX eyed at a […]